News | Leadership

HFMA recognizes the winners of its 2020-2021 Best Article Award

News | Leadership

HFMA recognizes the winners of its 2020-2021 Best Article Award

The award-winning articles were selected by a panel of five leaders in the healthcare industry who review each expert-reviewed article published in hfm.

HFMA is pleased to recognize the winners and runners-up of the Helen Yerger/L. Vann Seawell Best Article Award for outstanding editorial achievement in hfm magazine in fiscal year 2020-2021. Articles are judged on the writers’ demonstration of technical quality and writing skills and contributions to the literature of healthcare finance professionals.

Best articles

The following three articles are the FY21 recipients of HFMA’s Best Article Award. The runners-up are recognized together.

BEST ARTICLE | May 2021 hfm

“The economics of a telehealth visit: A time-based study at Penn Medicine”

By Neil Ravitz, MBA, Sean Looby, MHA, Calvin Jordan, MBA, and Andrew Kanoff, MHA

Summary: Research into the costs of delivering telehealth versus in-person visits by the Department of Orthopaedics at Penn Medicine sought to answer the health system's questions about the long-term economic viability of telemedicine services, and to help inform their conversations with payers about how much they should appropriately be paid for the services.

Neil Ravitz, MBA

Sean Looby, MHA

Calvin Jordan, MBA

Andrew Kanoff, MHA

BEST ARTICLE | October 2020 hfm

“Telemedicine is exploding, but where is the ROI for health systems?”

By Ezra Mehlman, MBA, and Dave Tamburri, MBA

Summary: As a result of the COVID-19 crisis, telehealth has gained broader acceptance and use than was seen at any time prior to the pandemic. Yet barriers and challenges continue to impede its widespread adoption. Economic models used by leading health systems provide insight into how to overcome these barriers to achieve a successful ongoing virtual enterprise.

Ezra Mehlman, MBA

Dave Tamburri, MBA

BEST ARTICLE | September 2020 hfm

“How to develop a winning pricing strategy in the post-COVID-19 consumer market”

By Kevin Sears, MHA, and Christopher Sukenik, MBA

Summary: Providers and health plans should prepare for federally imposed price transparency mandates by developing comprehensive pricing strategies tailored to their specific market positions, financials and operational objectives. These organizations should consider key implications of the price transparency rule and market trends when designing such a strategy.

 Kevin Sears, MHA

Christopher Sukenik, MBA


Runners-up, Best Article

Summer 2020 hfm

“How to leverage the telemedicine surge to create a profitable telehealth model”

By Lucy Zielinski and Daniel J. Marino

Summary: Healthcare finance leaders can help their organizations establish profitable telehealth programs following the COVID-19 pandemic by focusing now on the economic and operational drivers that will determine the success or failure of such programs.

Summer 2020 hfm

“Optimal use of APPs can enhance a health system’s post-COVID-19 financial recovery”

By Zachary Hartsell, DHA, PA-C, Dane Ficco and Laurie English

Summary: A strategy by Excela Health in Pennsylvania, which focused on integrating and optimizing the advanced practice provider workforce, offers a practical road map for how best to pursue such an undertaking.

February 2021 hfm

“340B Program success depends on the quality of self-auditing”

By Brian Matney,  CHFP, CPA

Summary: Healthcare organizations participating in the 340B Drug Pricing Program should self-audit their compliance with the program to ensure its ongoing success and effectiveness.

About the Author

Deborah Filipek

is a senior editor, HFMA, Westchester, Il.

Sign up for a free guest account and get access to five free articles every month.


Related Articles | Leadership

How To | Cost Effectiveness of Health

Cost Effectiveness of Health Report, December 2021

The December HFMA’s Cost Effectiveness of Health Report, sponsored by Kaufman Hall, leads off with the fourth and final report for 2021 in HFMA’s Healthcare 2030 series, focused on the long-term direction of strategic investment for hospitals and health systems. Also included are an article describing a new “employer-friendly” model of center of excellence and a commentary on how the FDA’s accelerated approval process may unintentionally be increasing the nation’s drug expense.

How To | Cost Effectiveness of Health

Recruitment and retention strategies can help mitigate impacts of the Great Resignation

To maintain a high-quality workforce, hospitals and health systems must take deliberate steps to address common pitfalls in the recruiting process and to adopt proven strategies for enhancing retention.

Column | Leadership

Relief meets reality: The pandemic is not over yet

HFMA President and CEO Joe Fifer reflects on another challenging year for healthcare.

Column | Leadership

Jill Geisler: The gift of time (well spent) maybe the best thing you can give your team

Leaders are one of the greatest influences on work-life harmony. Jill Geisler shares how healthcare finance leaders can give their teams the gift of time well spent and create a culture where work-life harmony flourishes.